{"id":1040543,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Below-Knee Amputation - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-10","captureTimestamp":"2026-03-10T10:14:37.902000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53777.html","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Below-Knee Amputation A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) What is the issue? Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of drugs used in the second- or…","rawSnapshotUrl":"/api/snapshots/raw/1040543","browseUrl":"https://replay.healtharchive.ca/job-8/20260310101437/https://cihr-irsc.gc.ca/e/53777.html#ha_snapshot=1040543","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}